Scott Donlea

Denargo Capital LLC (Denargo Capital) is a private equity firm founded in 2003 by Tom D. Heule, Pål Berg and Paul A. Lyons. The firm is headquartered in Greenwood Village, Colorado.

RCC is a Norwegian company that focuses on kidney cancer, which is one of the top 10 most commonly diagnosed forms of cancer among both men and women in the United States. Clear cell RCC is the most common type of kidney cancer in adults, while NCCRCC represents about 20-25%% of RCC cases, with fewer treatment options available and poorer outcomes compared with clear cell RCC. The company highlights the importance of early detection, as the five-year survival rate is high for patients with early-stage RCC. However, for patients with advanced or late-stage metastatic RCC, the five-year survival rate is only 14%%. RCC was acquired by AGR Ability Group on January 18, 2005 for $22.35 million.